$FORM · FORMFACTOR INC
FormFactor, Inc. entered into a Securities Purchase Agreement with Teradyne, Inc. on October 6, 2026, agreeing to sell 2,234,887 shares of common stock in a private placement for aggregate cash consideration of approximately $300.0 million. The transaction is expected to close in Q4 fiscal 2026, subject to customary closing conditions.
- FormFactor entered into a Securities Purchase Agreement with Teradyne, Inc. on October 6, 2026.
- 2,234,887 shares of common stock will be issued for aggregate cash consideration of approximately $300.0 million.
- The transaction is a private placement exempt from registration under Section 4(a)(2) of the Securities Act.
- Closing is expected in Q4 fiscal 2026, subject to customary closing conditions.
- The implied per-share price is approximately $134.24, a premium to the current $130.28 market price.
Markets closed — no regular-session reaction yet. Extended-hours last trade at $129.00, down 0.98% from the regular close of $130.28, suggesting mild initial skepticism on the $10.16B market-cap company.
A $300M strategic equity investment by Teradyne, a major semiconductor test peer, reshapes FormFactor's shareholder base and signals potential deeper industry consolidation.
Teradyne, a major semiconductor test equipment provider, taking a ~$300M equity stake in FormFactor (probe cards and test solutions) signals deepening strategic alignment in the semiconductor test ecosystem.
The transaction is subject to customary closing conditions and may not close as expected in Q4 fiscal 2026. The issuance represents dilution to existing shareholders of approximately 2.9% based on shares outstanding.
Get filings like this before the market reacts.
Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.